Literature DB >> 12126586

Neuropsychiatric involvement in systemic lupus erythematosus.

David Hermosillo-Romo1, Robin L Brey.   

Abstract

The correct diagnosis of central and peripheral nervous system manifestations in patients with systemic lupus erythematosus (SLE) can be challenging because of many SLE-related and non-SLE-related processes that can be present in a patient. The American College of Rheumatology (ACR) has published case definitions for 19 neuropsychiatric SLE (NPSLE) syndromes, with careful attention to important exclusion criteria. These criteria were developed for research purposes but can be helpful to clinicians with a patient who has nervous system dysfunction. This report reviews the data regarding the application of the ACR NPSLE criteria and the influence of ethnicity and disease duration on the development of NPSLE syndromes. Cognitive dysfunction and psychiatric disorders are the two most common manifestations. The work-up and treatment of nervous system syndromes are also discussed.

Entities:  

Mesh：

Year:  2002        PMID： 12126586     DOI： 10.1007/s11926-002-0043-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  44 in total

1.  "Subcortical" cognitive impairment in patients with systemic lupus erythematosus.

Authors:  E Leritz; J Brandt; M Minor; F Reis-Jensen; M Petri
Journal:  J Int Neuropsychol Soc       Date:  2000-11       Impact factor: 2.892

2.  Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations.

Authors:  N S Lai; J L Lan
Journal:  Lupus       Date:  2000       Impact factor: 2.911

Review 3.  Neuropsychiatric lupus: nomenclature, classification, criteria, and other confusional states.

Authors:  A P Ruggieri
Journal:  Arthritis Rheum       Date:  2001-10

4.  Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  F B Karassa; J P Ioannidis; K A Boki; G Touloumi; M I Argyropoulou; K A Strigaris; H M Moutsopoulos
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

5.  Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study.

Authors:  M Segasothy; P A Phillips
Journal:  Lupus       Date:  2001       Impact factor: 2.911

6.  Evaluation of cerebrospinal fluid for the presense of anticardiolipin antibodies (aCL) in NP-SLE patients.

Authors:  A Jedryka-Góral; J Zabek; B Wojciechowski; J Zaborski; H Chwalińska-Sadowska; A Członkowska
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

7.  Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study.

Authors:  A E Traynor; J Schroeder; R M Rosa; D Cheng; J Stefka; S Mujais; S Baker; R K Burt
Journal:  Lancet       Date:  2000-08-26       Impact factor: 79.321

8.  Risk factors for central nervous system involvement in systemic lupus erythematosus.

Authors:  F B Karassa; J P Ioannidis; G Touloumi; K A Boki; H M Moutsopoulos
Journal:  QJM       Date:  2000-03

9.  A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992.

Authors:  J Thumboo; K Uramoto; W M O'Fallon; K Y Fong; M L Boey; P H Feng; S T Thio; S E Gabriel; H H Chng; H S Howe; E T Koh; W H Koh; K H Leong; K P Leong
Journal:  Arthritis Rheum       Date:  2001-12

10.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910
View more
  7 in total

1.  A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?

Authors:  David R Spiegel; Lindsay Holtz; Kokil Chopra
Journal:  Psychiatry (Edgmont)       Date:  2010-04

2.  Prolonged coma from refractory status epilepticus.

Authors:  Saqib I Dara; Lori A Tungpalan; Edward M Manno; Vivien H Lee; Kevin G Moder; Mark T Keegan; Jimmy R Fulgham; Daniel R Brown; Keith H Berge; Francis X Whalen; Tuhin K Roy
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  The impact and implications of neuropsychiatric systemic lupus erythematosus in adolescents.

Authors:  Marisa Klein-Gitelman; Hermine I Brunner
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 4.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.

Authors:  J G Hanly; M B Urowitz; L Su; S-C Bae; C Gordon; A Clarke; S Bernatsky; A Vasudevan; D Isenberg; A Rahman; D J Wallace; P R Fortin; D Gladman; J Romero-Diaz; J Romero-Dirz; J Sanchez-Guerrero; M A Dooley; I Bruce; K Steinsson; M Khamashta; S Manzi; R Ramsey-Goldman; G Sturfelt; O Nived; R van Vollenhoven; M Ramos-Casals; C Aranow; M Mackay; K Kalunian; G S Alarcón; B J Fessler; G Ruiz-Irastorza; M Petri; S Lim; D Kamen; C Peschken; V Farewell; K Thompson; C Theriault; J T Merrill
Journal:  Ann Rheum Dis       Date:  2011-10       Impact factor: 19.103

6.  Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus.

Authors:  Xiaojuan Han; Tianshu Xu; Congzhu Ding; Dandan Wang; Genhong Yao; Hongwei Chen; Qijun Fang; Gang Hu; Lingyun Sun
Journal:  Signal Transduct Target Ther       Date:  2022-02-18

7.  Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.

Authors:  J G Hanly; M B Urowitz; F Siannis; V Farewell; C Gordon; S C Bae; D Isenberg; M A Dooley; A Clarke; S Bernatsky; D Gladman; P R Fortin; S Manzi; K Steinsson; I N Bruce; E Ginzler; C Aranow; D J Wallace; R Ramsey-Goldman; R van Vollenhoven; G Sturfelt; O Nived; J Sanchez-Guerrero; G S Alarcón; M Petri; M Khamashta; A Zoma; J Font; K Kalunian; J Douglas; Q Qi; K Thompson; J T Merrill
Journal:  Arthritis Rheum       Date:  2008-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.